Skip to main content

Table 1 Patient Characteristics

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Total Patients

95

100%

Median Age Years (range)

64 (34–84)

 

Sex

  

   Female

49

52%

   Male

46

48%

Race

  

   African American

21

22%

   Caucasian

74

78%

Primary Disease

  

   Colon

82

86%

   Rectal

13

14%

Performance Status

  

   0

35

37%

   1

52

55%

   2

8

8%